biote Corp. (BTMD): Capital Expenditures

Annual figures by period end, from SEC filings.

$5.01M

Year ended 2025-12-31

$4.50M

Trailing 12 months to 2026-06-30

+146.9%

3-year compound annual growth

2021-12-31 Capital Expenditures (USD) 2025-12-31

Period ended	Capital Expenditures	Change YoY	Source filing
2025-12-31	$5.01M	-22.0%	2026-03-13, From 2025-01-01
2024-12-31	$6.43M	n/m	2026-03-13, From 2024-01-01
2023-12-31	$359.0K	+7.8%	2025-03-14, From 2023-01-01
2022-12-31	$333.0K	-77.0%	2024-03-15, From 2022-01-01
2021-12-31	$1.45M	n/a	2023-03-29, From 2021-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Capital Expenditures	Change YoY
biote Corp. (BTMD)	2025-12-31	$5.01M	-22.0%
Glass House Brands Inc. (GLAS)	2025-12-31	$27.18M	+164.0%
Marimed Inc. (MRMD)	2025-12-31	$1.17M	-90.2%
Cronos Group Inc. (CRON)	2025-12-31	$25.72M	+107.2%
Natural Alternatives International Inc (NAII)	2026-06-30	$3.70M	+2.4%
Jushi Holdings Inc. (JUSH)	2025-12-31	$16.09M	+241.8%
Mannatech Inc (MTEX)	2025-12-31	$1.35M	+355.6%
Fitlife Brands, Inc. (FTLF)	2025-12-31	$42.0K	+320.0%
Ascend Wellness Holdings, Inc. (AAWH)	2025-12-31	$26.01M	+15.4%

Compare BTMD, GLAS, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗